132 related articles for article (PubMed ID: 27884394)
21. Pulmonary veno-occlusive disease and the CREST variant of scleroderma.
Morassut PA; Walley VM; Smith CD
Can J Cardiol; 1992 Dec; 8(10):1055-8. PubMed ID: 1288837
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary hypertension: CT findings in pulmonary veno-occlusive disease].
Resten A; Maître S; Capron F; Simonneau G; Musset D
J Radiol; 2003 Nov; 84(11 Pt 1):1739-45. PubMed ID: 15022986
[TBL] [Abstract][Full Text] [Related]
23. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
[TBL] [Abstract][Full Text] [Related]
24. Mitomycin--C-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: cumulative toxicity of an old drug in a new era.
El-Ghazal R; Podoltsev N; Marks P; Chu E; Saif MW
Clin Colorectal Cancer; 2011 Jun; 10(2):142-5. PubMed ID: 21859568
[TBL] [Abstract][Full Text] [Related]
25. Fatal pulmonary veno-occlusive disease after chemotherapy for Burkitt's lymphoma.
Miyata D; Fukushima T; Matsunaga M; Saito N; Kato Y; Takahashi-Igari M; Horigome H; Sumazaki R; Yamaki S; Matsui A
Pediatr Int; 2011 Jun; 53(3):403-5. PubMed ID: 21696511
[No Abstract] [Full Text] [Related]
26. Pulmonary Veno-Occlusive Disease and Pulmonary Fibrosis in a Family with
Vetel K; Eyries M; Savale L; Kanengiesser C; Borie R; Humbert M; Montani D
Am J Respir Cell Mol Biol; 2024 Feb; 70(2):143-145. PubMed ID: 38299797
[No Abstract] [Full Text] [Related]
27. Occult alveolar haemorrhage in pulmonary veno-occlusive disease.
Rabiller A; Jaïs X; Hamid A; Resten A; Parent F; Haque R; Capron F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2006 Jan; 27(1):108-13. PubMed ID: 16387942
[TBL] [Abstract][Full Text] [Related]
28. A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.
Fabrice A; Benoît R; Valérie N; Lau E; Sébastien B; Frédéric P
Anal Cell Pathol (Amst); 2015; 2015():326385. PubMed ID: 26345623
[TBL] [Abstract][Full Text] [Related]
29. [A 24-year-old male patient with pulmonary veno-occlusive disease - case report].
Cwiek E; Przemęcka M; Marczak J; Kuś J; Langfort R; Górski P
Pneumonol Alergol Pol; 2014; 82(3):271-5. PubMed ID: 24793152
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension.
Johnson SR; Patsios D; Hwang DM; Granton JT
J Rheumatol; 2006 Nov; 33(11):2347-50. PubMed ID: 16981286
[TBL] [Abstract][Full Text] [Related]
31. A very rare side effect of mitomycin-C: psoriasiform drug eruption.
Cicek D; Cobanoglu B; Inci R; Dertlioglu SB; Kokcam I; Elkiran T
Int J Dermatol; 2013 Dec; 52(12):1572-4. PubMed ID: 24261729
[No Abstract] [Full Text] [Related]
32. Necrosis of the glans penis: a rare complication of intravesical therapy with mitomycin c.
Neulander EZ; Lismer L; Kaneti J
J Urol; 2000 Oct; 164(4):1306. PubMed ID: 10992393
[No Abstract] [Full Text] [Related]
33. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.
Runo JR; Vnencak-Jones CL; Prince M; Loyd JE; Wheeler L; Robbins IM; Lane KB; Newman JH; Johnson J; Nichols WC; Phillips JA
Am J Respir Crit Care Med; 2003 Mar; 167(6):889-94. PubMed ID: 12446270
[TBL] [Abstract][Full Text] [Related]
34. A new mutation in the EIF2AK4 gene in familial pulmonary veno-occlusive disease.
Jonas K; Żuławińska B; Borys A; Wołkow P; Małecki M; Kopeć G
Pol Arch Intern Med; 2023 Mar; 133(3):. PubMed ID: 36633383
[No Abstract] [Full Text] [Related]
35. [Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension].
Karakurt Z
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():63-8. PubMed ID: 20819769
[TBL] [Abstract][Full Text] [Related]
36. Urethral slough: a rare and previously unreported complication of intravesical mitomycin.
Brady JD; Assimos DG; Jordan GH
J Urol; 2000 Oct; 164(4):1305. PubMed ID: 10992392
[No Abstract] [Full Text] [Related]
37. Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. Case presentation and review of the literature .
Daraban AM; Enache R; Predescu L; Platon P; Constantinescu T; Mihai C; Coman IM; Ginghina C; Jurcuţ R
Rom J Intern Med; 2015; 53(2):175-83. PubMed ID: 26402988
[TBL] [Abstract][Full Text] [Related]
38. The potential of amifostine: from cytoprotectant to therapeutic agent.
Santini V; Giles FJ
Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
Vujaskovic Z; Feng QF; Rabbani ZN; Samulski TV; Anscher MS; Brizel DM
Exp Lung Res; 2002; 28(7):577-90. PubMed ID: 12396250
[TBL] [Abstract][Full Text] [Related]
40. Amifostine and curative intent chemoradiation for compromised cancer patients.
Nguyen NP; Levinson B; Dutta S; Karlsson U; Kelly KC; Dowell J; Ludin A; Sallah S
Anticancer Res; 2003; 23(2C):1649-56. PubMed ID: 12820436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
